Redwire Corp (RDW) said Monday it has expanded its in-space drug development program by launching a new drug development technology and a cancer-detection experiment to the International Space Station.
The company launched an industrial crystallizer to process more enhanced samples that could be previously processed in the original PIL-BOX technology, Redwire added.